Summary
α1-6 Fucosyltransferase (α1-6FucT) catalyzes the transfer of fucose from GDP-Fuc to N-linked type complex glycoproteins. Recently, serum α1-6 fucosylated α-fetoprotein (AFP) has been employed for a differential diagnosis of hepatocellular carcinoma (HCC) from liver cirrhosis. To determine the molecular basis of the fucosylated AFP in the serum of patients with HCC, we have succeeded in the purification and cDNA cloning of α1-6FucT from porcine brain and a gastric cancer cell line, respectively. Their homology is 92.2% at the nucleotide level and 95.7% at the amino acid level. No putative N-glycosylation sites were found in the predicted amino acid sequence. α1-6FucT was widely expressed in various rat tissues except normal liver. Expression of α1-6FucT in the liver was enhanced during hepatocarcinogenesis of LEC rats, which develop hereditary hepatitis and hepatomas. In human liver diseases, α1-6FucT was expressed in both HCCs and their surrounding tissues with chronic liver disease, but not in normal liver. Although serum AFP has been employed for an early diagnosis of patients with HCC, the mechanisms by which α1-6 fucosylation of AFP occurs in HCC seem to be not solely due to the up-regulation of α1-6FucT. Interestingly, when the α1-6FucT gene was transfected into Hep3B, a human hepatoma cell line, tumor formation in the liver of nude mice after splenic injection was dramatically suppressed. The mechanisms of the suppression were due to decreases in cell adhesion through aberrant glycosylation of α5β1 integrin. In this review, we focus on the biological significance of α1-6 fucosylation in HCC.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hakomori S-I (1989) Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 52: 257–331
Wilson JR, Williams D, Schachter H (1976) The control of glycoprotein synthesis: N-acetylglucosamine linkage to a mannose residue as a signal of L-fucose to the asparagine-linked N-acetylglucosamine residue of glycopeptide from al-acid glycoprotein. Biochem Biophys Res Commun 72: 909–916
Longmore GD, Schachter H (1982) Product-identification and substrate specificity studies of the GDP-fucose:2-acetamide-2-deoxy-β-D-glucoside (Fuc-linked GlcNAc)6a-L-fucosyltransferase in a Golgi-rich fraction from porcine liver. Carbohydr Res 100: 365–392
Shimizu H, Ochiai K, Ikenaka K, et al. (1993) Structures of N-linked sugar chains expressed mainly in mouse brain. J Biochem 114: 334–338
Yamashita K, Liang C-J, Funakoshi S, et al. (1981) Structural studies of asparagine-linked sugar chains of human ceruloplasmin. J Biol Chem 256: 1283–1289
Yamashita K, Ideo H, Ohkura T, et al. (1993) Sugar chains of serum transferrin from patients with carbohydrate deficient glycoprotein syndrome. J Biol Chem 268: 5783–5789
Santer UV, Glick MC (1979) Partial structure of a membrane glycopeptide from virus-transformed hamster cells. Biochemistry 18: 2533–2540
Brzborowicz J, Mackiewicz A, Brzborowicz D (1981) Microheterogeneity of afetoprotein in patient serum as demonstrated by lectin affino-electrophoresis. Scand J Immunol 14: 15–20
Taketa K, Ichikawa E, Umetsu K, et al. (1986) Allomyrina dichotoma lectin-nonreactive a-fetoprotein in hepatocellular carcinoma and other tumors: comparison with Ricinus communis agglutinin-I. Cancer Lett 31: 325–331
Champion B, Leger D, Wieruszeski J-M, et al. (1989) Presence of fucosylated triantennary, tetraantennary and pentaantenary glycans in transferrin synthesized by the human hepatocarcinoma cell line HepG2. Eur J Biochem 184: 405–413
Koscielak J, Pacuszka T, Kubin J, et al. (1987) Serum α-6-L-fucosyltransferase is released from platelets during clotting of blood. Glycoconjugate J 4: 43–49
Koscielak J, Antoniewicz-Papis J, Zdebska E, et al. (1995) Activity of platelet a-6fucosyltransferase is inversely related to blood platelet concentration. Acta Biochim Polon 42: 35–39
Tatsumura T, Sato H, Mori A, et al. (1997) Clinical significance of fucose level in glycoprotein fraction of serum in patients with malignant tumors. Cancer Res 37: 4101–4103
Uozumi N, Yanagidani S, Miyoshi E, et al. (1996) Purification and cDNA cloning of porcine brain GDP-L-Fuc:N-acetyl-13-D-glucosaminide:a1–6 fucosyltransferase. J Biol Chem 271: 27810–27817
Yanagidani S, Uozumi N, Ihara Y, Miyoshi E, et al. (1997) Purification and cDNA cloning of GDP-L-Fuc:N-acetylglucosaminide:al-6 fucosyltransferase (a1–6FucT) from human stomach carcinoma MKN45 cells. J Biochem 121: 626–632
Wang YM, Hare TR, Won B, et al. (1990) Additional fucosyl residues on membrane glycoproteins but not on secreted glycoprotein from cystic fibrosis fibroblasts. Clin Chim Acta 188: 193–210
Voynow JA, Kaiser RS, Scanlin TF, et al. (1991) Purification and characterization of GDP-L-Fuc:N-acetyl-(3-D-glucosaminide al-6 fucosyltransferase from cultured human skin fibroblasts. J Biol Chem 266: 21572–21577
Breton C, Oriol R, Imberty A (1998) Conserved structural features in eukaryotic and prokaryotic fucosyltransferases. Glycobiology 8: 87–94
Miyoshi E, Uozumi N, Noda K, et al. (1997) Expression of al-6 fucosyltransferase in rat tissues and human cancer cell lines. Int J Cancer 72: 1117–1121
Kaminska J, Glick MC, Koscielak J (1998) Purification and characterization of GDPL-Fuc:N-acetyl (3-D-glucosaminide a1–6 fucosyltransferase from human blood platelets. Glycoconjugate J 15: 783–788
Bergstrand CG, Czar B (1956) Demonstration of new protein fraction in serum from the human fetus. Scand J Clin Lab Invest 8: 174
Halbrecht I, Klibanski C (1956) Identification of a new normal embryonic hemoglobin. Nature 178: 794–795
Abelev GI, Perova SD, Khramkova NI, et al. (1963) Production of embryonal a-globulin by transplantable mouse hepatomas. Transplant Bull 1: 174–180
Tatarinov YS (1963) The discovery of fetal globulin in patients with primary cancer of the liver. First International Biochemistry Congress of the USSR. Moscow: Academy of Sciences USSR, 274
Tatarinov YS (1964) Presence of embryo specific a-globulin in the serum of patients with primary hepatocellular carcinoma. Vopr Med Khim 10: 90–91
Alpert ME, Uriel J, de Nechaud B (1968) al Fetogloblin in the diagnosis of human hepatoma. N Engl J Med 278: 984–986
Di Bisceglie AM, Hoofnagle JH (1989) Elevations in serum a-fetoprotein levels in patients with chronic hepatitis B. Cancer 64: 2117–2120
Sawadaishi K, Morinaga T, Tamaoki T (1988) Interaction of a hepatoma-specific nuclear factor with transcription-regulatory sequences of human a-fetoprotein and albumin genes. Mol Cell Biol 8: 5179–5187
Nakabayashi H, Watanabe K, Saito A, et al. (1989) Transcriptional regulation of afetoprotein expression by dexamethasone in human hepatoma cells. J Biol Chem 264: 266–271
Morinaga T, Sakai M, Wegmann TG, et al. (1983) Primary structures of human afetoprotein and its mRNA. Proc Natl Acad Sci USA 80: 4604–4608
Gibbs PEM, Zielinski R, Boyd C, et al. (1987) Structure, polymorphism and novel repeated DNA elements revealed by a complete structure of the human a-fetoprotein gene. Biochemistry 26: 1332–1343
Breborowicz J, Mackiewicz A, Breborowicz D (1981) Microheterogeneity of afetoprotein in patient serum as demonstrated by lectin affino-electrophoresis. Scand J Immunol 14: 15–20
Miyazaki J, Endo Y, Oda T (1981) Lectin affinities of a-fetoprotein in liver cirrhosis, hepatocellular carcinoma and metastatic liver tumor. Acta Hepatol Jpn 22: 1559–1568
Kornfeld K, Reitman ML, Kornfeld R (1981) The carbohydrate-binding specificity of pea and lentil lectins. J Biol Chem 256: 6633–6640
Taketa K, Ichikawa E, Taga H, et al. (1985) Antibody-affinity blotting, a sensitive technique for the detection of a-fetoprotein separated by lectin affinity electrophoresis in agarose gels. Electrophoresis 6: 492–497
Aoyagi Y, Suzuki Y, Igarashi K, et al. (1991) The usefulness of simultaneous determinations of glucosaminylation and fucosylation induces of a-fetoprotein in the differential diagnosis of neoplastic diseases of the liver. Cancer 67: 2390–2394
Taketa K, Sekiya C, Namiki M, et al. (1990) Lectin-reactive profiles of a-fetoprotein characterizing hepatocellular carcinoma and related conditions. Gastroenterology 99: 508–518
Taketa K, Endo Y, Sekiya C, et al. (1993) A collaborative study for the evaluation of lectin-reactive a-fetoprotein in early detection of hepatocellular carcinoma. Cancer Res 53: 5419–5423
Sato Y, Nakata K, Kato Y, et al. (1993) Early recognition of hepatocellular carcinoma based on altered profiles of a-fetoprotein. N Engl J Med 328: 1802–1806
Shiraki K, Takase K, Tameda Y, et al. (1995) A clinical study of lectin-reactive afetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients. Hepatology 22: 802–807
Yamashita F, Tanaka M, Satomura S, et al. (1996) Prognostic significance of Lens Culinaris Agglutinin-reactive a-fetoprotein in small hepatocellular carcinomas. Gastroenterology 111: 996–1001
Aoyagi Y, Isokawa O, Suda T, et al. (1998) The fucosylation index of a-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma. Cancer 83: 2076–2082
Miyoshi E, Fujii J, Hayashi N, et al. (1997) LEC rats: an overview of recent findings. J Trace Elem Exp Med 10: 135–145
Noda K, Miyoshi E, Uozumi N, et al. (1998) High expression of al-6 fucosyltransferase during rat hepatocarcinogenesis. Int J Cancer 75: 444–450
Hutchinson WL, Du M-Q, Johnson PJ, et al. (1991) Fucosyltransferases: differential plasma and tissue alterations in hepatocellular carcinoma and cirrhosis. Hepatology 13: 683–688
Noda K, Miyoshi E, Uozumi N (1998) Gene expression of al-6 fucosyltransferase in human hepatoma tissues: a possible implication for increased fucosylation of a feto-protein. Hepatology 28: 944–952
Miyoshi E, Noda K, Ko JH, et al. (1999) Overexpression of a1–6 fucosyltransferase in hepatoma cells suppresses intrahepatic metastasis after splenic injection in athymic mice. Cancer Res 59: 2237–2243
Stubbs HJ, Lih JJ, Gustafson TL, et al. (1996) Influence of core fucosylation on the flexibility of a biantennary N-linked oligosaccharide. Biochemistry 35: 937–947
Kojima N, Yachida Y, Yoshida Y, et al. (1996) Characterization of mouse ST SialI(STX) as a neural cell adhesion molecule-specific polysialic acid synthase. J Biol Chem 271: 19457–19463
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Tokyo
About this paper
Cite this paper
Miyoshi, E., Noda, K., Taniguchi, N., Sasaki, Y., Hayashi, N. (2001). Significance of α1-6 Fucosylation in Hepatocellular Carcinoma. In: Okita, K. (eds) Liver Cirrhosis. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68343-8_12
Download citation
DOI: https://doi.org/10.1007/978-4-431-68343-8_12
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-68345-2
Online ISBN: 978-4-431-68343-8
eBook Packages: Springer Book Archive